Mesna + Paclitaxel + Ifosfamide for neoplasms, germ cell and embryonal

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 10 Jun 2013: Trial registered, NCT01873326

The trials

NCT01873326: Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors

State
Under way
Phase
Phase 2
People
92 taking part
Started
Jun 2013
Primary completion
Jun 2027
Arms
Paclitaxel, Ifosfamide and Cisplatin (TIP)
Results
None posted
  1. 10 Jun 2013: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.